Bioethics News

Cord Blood: Big Business, Small Benefits

February 27, 2017

(The Times of India) – Private banking of umbilical cord blood is a big business running parallel to childbirth in big hospitals, but is it worth the cost? While companies offering the facility for a few thousand rupees claim it can be used to treat conditions ranging from cerebral palsy to diabetes, health experts and doctors disagree. They say stem cell transplantation for treatment is limited to hereditary or genetic conditions, specifically blood disorders.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.